Author

Nana Koram 1

1 Pfizer Inc,New York,United States

CLOSTRIDIUM DIFFICILE INFECTION IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS PROGRAMME: AN UPDATE AS OF MAY 2019

Edward V Loftus Jr., Alessandro Armuzzi, Daniel C. Baumgart, Jeffrey R Curtis, Jami A. Kinnucan, Nana Koram, Leonardo Salese, Chinyu Su, Kenneth Kwok, John Woolcott

Incidence of venous thromboembolic events in patients with ulcerative colitis treated with tofacitinib in the ulcerative colitis clinical development programme

William Sandborn, Julian Panés, Bruce E. Sands, Walter Reinisch, Chinyu Su, Nervin Lawendy, Nana Koram, Haiyun Fan, Thomas V Jones, Irene Modesto, Daniel Quirk, Silvio Danese

WORLDWIDE POST-MARKETING SAFETY SURVEILLANCE EXPERIENCE WITH TOFACITINIB IN ULCERATIVE COLITIS

Kenneth Kwok, Severine Vermeire, Irene Modesto, David T. Rubin, Silvio Danese, Siew C. Ng, Nana Koram, Thomas V Jones

Item 1 - 3 / 3
1